NCCN 3rd Annual Congress:
Hematologic Malignancies™
Agenda
Friday, September 5, 2008
Registration, Breakfast, and Exhibits
7:30 - 8:45 AM
Welcome
8:45 – 8:55 AM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
Lymphomas
Treatment of Acute Lymphocytic Leukemia
8:55 – 9:55 AM
Speaker TBD
Treatment of Cutaneous T-cell Lymphoma
10:00 – 10:45 AM
Youn H. Kim, MD
Stanford Comprehensive Cancer Center
Break and Exhibits
10:45 – 11:05 AM
Radioimmunotherapy in Lymphomas
11:05 – 11:50 AM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
Lunch and Exhibits
11:50 AM – 12:50 PM
The Evolving Role of Multi-Modality Therapy in Hodgkin’s Lymphoma
12:50 – 1:35 PM
Leo I. Gordon, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Role of PET in the Diagnosis and Management of Lymphomas
1:40 – 2:25 PM
Steven M. Horwitz, MD
Memorial Sloan-Kettering Cancer Center
Break and Exhibits
2:25 – 2:45 PM
Chronic Myelogenous Leukemia
Management of Progressive Disease
2:45 – 3:30 PM
Jerald P. Radich, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Management of Tyrosine Kinase Inhibitor Toxicity
3:35 – 4:20 PM
Susan O’Brien, MD
The University of Texas M. D. Anderson Cancer Center
Closing Remarks
4:25 – 4:30 PM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
Reception and Exhibits
4:30 – 6:15 PM
Saturday, September 6, 2008
8:00 AM – 12:45 PM
Registration & Breakfast
7:30 – 8:00 AM
Welcome
8:00 – 8:05 AM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
Multiple Myeloma
Sequencing of Therapies for Multiple Myeloma
8:05 – 8:50 AM
Seema Singhal, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Supportive Care in Multiple Myeloma
8:55 – 9:40 AM
Kenneth C. Anderson, MD
Dana-Farber/Brigham and Women’s Cancer Center
Supportive Care
Anemia and Myelodysplastic Syndromes
9:45 – 10:30 AM
Peter L. Greenberg, MD
Stanford Comprehensive Cancer Center
Break
10:30 – 10:50 AM
Panel Discussion – ESAs: Risk Benefit Analysis
10:50 – 11:50 AM
Pamela S. Becker, MD, PhD
University of Washington
Charles L. Bennett, MD, PhD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Eric H. Kraut, MD
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University
Issues in Advanced Directives: Changing Goals and Realities with Advancing Disease
11:55 AM – 12:40 PM
Cameron Muir, MD
Capital Hospice
Closing Remarks
12:40 – 12:45 PM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
View information on the NCCN 1st Annual Forum: Innovative Diagnostics & Therapeutics in Cancer Care™.
Last update 04/21/2008. Subject to change.
|
